Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $66,625 | 30 | 55.1% |
| Consulting Fee | $43,675 | 12 | 36.1% |
| Travel and Lodging | $6,842 | 20 | 5.7% |
| Food and Beverage | $3,538 | 129 | 2.9% |
| Education | $169.80 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $71,123 | 111 | $0 (2024) |
| CooperSurgical, Inc. | $48,480 | 39 | $0 (2024) |
| Astellas Pharma US Inc | $406.11 | 12 | $0 (2024) |
| Hologic Sales and Service, LLC | $112.36 | 1 | $0 (2024) |
| Evofem Biosciences, Inc. | $109.12 | 6 | $0 (2021) |
| Hologic, LLC | $104.55 | 2 | $0 (2021) |
| Stryker Corporation | $82.95 | 2 | $0 (2022) |
| Minerva Surgical, Inc | $80.53 | 2 | $0 (2022) |
| Myovant Sciences Inc. | $77.80 | 4 | $0 (2022) |
| Sumitomo Pharma America, Inc. | $71.43 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $428.04 | 12 | Astellas Pharma US Inc ($201.30) |
| 2023 | $335.65 | 11 | Astellas Pharma US Inc ($204.81) |
| 2022 | $2,091 | 19 | ABBVIE INC. ($1,648) |
| 2021 | $8,339 | 36 | AbbVie Inc. ($7,634) |
| 2020 | $8,197 | 16 | AbbVie Inc. ($7,247) |
| 2019 | $43,663 | 55 | AbbVie, Inc. ($43,475) |
| 2018 | $36,294 | 33 | CooperSurgical, Inc. ($25,270) |
| 2017 | $21,501 | 12 | CooperSurgical, Inc. ($21,426) |
All Payment Transactions
194 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/02/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $29.65 | General |
| Category: Biological | ||||||
| 08/14/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Biological | ||||||
| 08/02/2024 | CooperSurgical, Inc. | Endosee (Device) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Obstetrics/Gynecology (Women's Health) | ||||||
| 07/31/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $31.85 | General |
| Category: HORMONE THERAPY | ||||||
| 06/13/2024 | Hologic Sales and Service, LLC | MYOSURE TISSUE REMOVAL DEVICE (Device) | Food and Beverage | In-kind items and services | $112.36 | General |
| Category: Surgical | ||||||
| 06/05/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $30.05 | General |
| Category: Biological | ||||||
| 05/29/2024 | ABBVIE INC. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: WOMENS HEALTH | ||||||
| 05/23/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: HORMONE THERAPY | ||||||
| 04/24/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: CONTRACEPTIVE | ||||||
| 04/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: Biological | ||||||
| 02/29/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $69.99 | General |
| 02/07/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $25.11 | General |
| Category: Biological | ||||||
| 12/13/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Biological | ||||||
| 10/18/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: Biological | ||||||
| 09/13/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Biological | ||||||
| 08/10/2023 | ABBVIE INC. | LO LOESTRIN FE (Drug), ORILISSA | Food and Beverage | In-kind items and services | $26.01 | General |
| Category: WOMENS HEALTH | ||||||
| 08/02/2023 | Astellas Pharma US Inc | — | Education | In-kind items and services | $79.99 | General |
| 08/02/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $27.39 | General |
| Category: Biological | ||||||
| 06/21/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $26.10 | General |
| Category: Biological | ||||||
| 03/29/2023 | ABBVIE INC. | ORILISSA (Drug) | Food and Beverage | In-kind items and services | $26.11 | General |
| Category: WOMENS HEALTH | ||||||
| 03/15/2023 | ABBVIE INC. | ORILISSA (Drug) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: WOMENS HEALTH | ||||||
| 03/01/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: HORMONE THERAPY | ||||||
| 02/03/2023 | ABBVIE INC. | ORILISSA (Drug) | Food and Beverage | In-kind items and services | $37.26 | General |
| Category: WOMENS HEALTH | ||||||
| 12/08/2022 | CooperSurgical, Inc. | Mara Console (Device) | Food and Beverage | In-kind items and services | $75.00 | General |
| Category: Devices | ||||||
| 11/09/2022 | Myovant Sciences Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: HORMONE THERAPY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 328 | 370 | $100,731 | $34,292 |
| 2022 | 8 | 423 | 500 | $131,750 | $52,421 |
| 2021 | 8 | 390 | 495 | $141,049 | $58,926 |
| 2020 | 6 | 379 | 490 | $169,769 | $74,388 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 58558 | Biopsy of lining of uterus and/or removal of polyp using an endoscope | Office | 2023 | 15 | 15 | $49,685 | $16,420 | 33.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 101 | 123 | $21,316 | $7,473 | 35.1% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 87 | 87 | $6,902 | $3,450 | 50.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 54 | 73 | $7,985 | $2,904 | 36.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 42 | 42 | $9,351 | $2,671 | 28.6% |
| 56605 | Biopsy of growth of external female genitals, first growth | Office | 2023 | 14 | 14 | $2,872 | $884.53 | 30.8% |
| 51701 | Insertion of temporary bladder tube | Office | 2023 | 15 | 16 | $2,620 | $490.37 | 18.7% |
| 58558 | Biopsy of lining of uterus and/or removal of polyp using an endoscope | Office | 2022 | 24 | 24 | $53,598 | $26,220 | 48.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 132 | 196 | $27,723 | $11,817 | 42.6% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 115 | 115 | $7,121 | $4,696 | 65.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 58 | 65 | $5,754 | $2,654 | 46.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 31 | 31 | $5,410 | $2,311 | 42.7% |
| 58558 | Biopsy of lining of uterus and/or removal of polyp using an endoscope | Facility | 2022 | 12 | 12 | $26,799 | $2,289 | 8.5% |
| 51701 | Insertion of temporary bladder tube | Office | 2022 | 21 | 27 | $1,919 | $904.53 | 47.1% |
| 56605 | Biopsy of growth of external female genitals, first growth | Office | 2022 | 16 | 16 | $2,479 | $899.95 | 36.3% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 14 | 14 | $948.22 | $629.09 | 66.3% |
| 58558 | Biopsy and/or removal of polyp of the uterus using an endoscope | Office | 2021 | 23 | 25 | $56,625 | $30,754 | 54.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 125 | 214 | $28,676 | $13,858 | 48.3% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 84 | 84 | $5,250 | $3,436 | 65.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 36 | 36 | $5,904 | $2,643 | 44.8% |
| 58558 | Biopsy and/or removal of polyp of the uterus using an endoscope | Facility | 2021 | 15 | 15 | $33,975 | $2,642 | 7.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 47 | 55 | $4,565 | $2,289 | 50.1% |
| 56605 | Biopsy of external female genitals, 1 lesion | Office | 2021 | 18 | 21 | $3,024 | $1,465 | 48.5% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 24 | 24 | $1,560 | $1,087 | 69.7% |
| 51701 | Insertion of temporary bladder catheter | Office | 2021 | 18 | 21 | $1,470 | $750.36 | 51.0% |
About Dr. Abigail Gregory, MD
Dr. Abigail Gregory, MD is a Obstetrics & Gynecology healthcare provider based in Oakland, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2007. The National Provider Identifier (NPI) number assigned to this provider is 1336346691.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Abigail Gregory, MD has received a total of $120,850 in payments from pharmaceutical and medical device companies, with $428.04 received in 2024. These payments were reported across 194 transactions from 16 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($66,625).
As a Medicare-enrolled provider, Gregory has provided services to 1,520 Medicare beneficiaries, totaling 1,855 services with total Medicare billing of $220,027. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Obstetrics & Gynecology
- Location Oakland, MD
- Active Since 06/29/2007
- Last Updated 08/30/2024
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1336346691
Products in Payments
- Orilissa (Drug) $43,529
- Endosee (Device) $26,805
- Other Gyn Products (Device) $21,347
- Lupron (Drug) $10,918
- ORIAHNN (Drug) $9,062
- ORILISSA (Drug) $7,501
- Veozah (Drug) $256.13
- Mara Console (Device) $237.50
- MYFEMBREE (Drug) $149.23
- MYOSURE TISSUE REMOVAL DEVICE (Device) $147.11
- LO LOESTRIN FE (Drug) $116.84
- Phexxi (Drug) $109.12
- Global Endometrial Abiation (Device) $91.30
- NOVASURE (Device) $69.80
- SPY-PHI SYSTEM (Device) $53.71
- LILETTA (Drug) $35.47
- 1588 (Device) $29.24
- MD cobas Instruments and Reagents (Device) $28.80
- INTRAROSA (Drug) $19.82
- ESTRACE CREAM (Drug) $17.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Oakland
Grace Cavallaro, Md, MD
Obstetrics & Gynecology — Payments: $15,899
Amanda Calhoun, Md, MD
Obstetrics & Gynecology — Payments: $9,041
Bonnie Zell, M.d, M.D
Obstetrics & Gynecology — Payments: $6,298
Dr. Arthur Levit, Md, MD
Obstetrics & Gynecology — Payments: $4,253
Yvette Gentry, M.d, M.D
Obstetrics & Gynecology — Payments: $3,863
Elizabeth Hur, Md, MD
Obstetrics & Gynecology — Payments: $2,131